Jessica L. Taylor, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Jessica L. Taylor, MD is an Assistant Professor of Medicine in General Internal Medicine at the Chobanian and Avedisian School of Medicine and Boston Medical Center and a board-certified Addiction Specialist. She attended Mount Sinai School of Medicine and completed internal medicine residency training at Beth Israel Deaconess Medical Center and Harvard Medical School, where she also served as a Chief Resident. Dr. Taylor’s clinical work focuses on the care of patients with substance use disorders, HIV, and viral hepatitis.

Her research interests include HIV prevention among people who inject drugs, HIV pre-exposure prophylaxis (PrEP) implementation, low-barrier substance use disorder treatment models, and overdose prevention. She is Co-Director of the Care Continuum Core for the Massachusetts site of the NIDA-funded Healing Communities Study, which aims to reduce fatal opioid overdose by 40%.

Dr. Taylor is the Medical Director of Faster Paths to Treatment, Boston Medical Center’s innovative, low-barrier substance use disorder bridge clinic and the Medical Director of the Transitional Care Clinic, a bridge clinic co-located with a low-threshold, transitional housing program for people experiencing homelessness. She directs HIV Prevention Programs at BMC. Her educational roles include directing the HIV Pathway for internal medicine residents and serving as core faculty in BUSM’s Addiction Medicine fellowship program.

Publications

  • Published 2/25/2025

    Palfai TP, Kratzer MPL, Taylor JL, Otis JD, Winter MR. Addressing Pain and Heavy Drinking among Patients in HIV-Care: A Pilot Study of an Integrated Telehealth Intervention. AIDS Behav. 2025 Jun; 29(6):1930-1943. PMID: 39998790.

    Read at: PubMed

  • Published 12/1/2024

    Li C, Burke MM, Taylor JL, DaWalt LS, Rossetti Z. Establishing an Advocacy Activities Scale for Parents of Individuals With Intellectual and Developmental Disabilities. Intellect Dev Disabil. 2024 Dec 01; 62(6):486-499. PMID: 39581212.

    Read at: PubMed

  • Published 11/27/2024

    De La Hoz A, Pooja A, Kancharla A, Schechter-Perkins EM, Ruiz-Mercado G, Baldwin M, Nunes D, Taylor JL. Characteristics and Outcomes of Direct-Acting Antiviral Experienced Patients with Hepatitis C Undergoing Retreatment at an Essential Hospital in the United States. Open Forum Infect Dis. 2024 Dec; 11(12):ofae704. PMID: 39703790.

    Read at: PubMed

  • Published 11/4/2024

    Rozansky H, Christine PJ, Younkin M, Fox JM, Weinstein ZM, Suarez S, Stewart J, Farrell N, Taylor JL. Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital. Addict Sci Clin Pract. 2024 Nov 04; 19(1):77. PMID: 39497126.

    Read at: PubMed

  • Published 10/14/2024

    De La Hoz A, Gadi N, Lopez CG, Barrera-Godinez A, Miller NS, Bourque DL, Brem C, Ozluk E, Seth G, Kimball S, Taylor JL. Immune Reconstitution Inflammatory Syndrome in a Patient With Cutaneous Leishmaniasis and HIV: A Diagnostic Challenge for Clinicians Caring for a Migrant Population in the United States. Open Forum Infect Dis. 2024 Oct; 11(10):ofae587. PMID: 39474451.

    Read at: PubMed

View All 52 Publications:   View Full Profile in BUMC

Other Positions

  • Faculty, Medicine
    Boston University Chobanian & Avedisian School of Medicine

Websites

Education

  • Mount Sinai School of Medicine, MD
  • Duke University, BS

View all profiles